Many organizations fail to consider what types of product codes are best for them. This white paper illustrates the importance of adopting a strategy that supports multiple serialization schemes and standards to address their various needs.
Brand protection solutions can drive a return on investment (ROI) through new sales, better customer loyalty, supply chain efficiency gains, fraud reduction and operational cost savings.
This white paper outlines how brands can get the most bang for their buck by using serialization, digital product authentication and Track&Trace.
Virtually unknown 10 years ago, event sourcing has now become the gold standard for financial databases. This white paper explains why, and how event sourcing leads to enhanced business intelligence, security and confidence.
A clear understanding of secure mass serialization, product authentication and traceability can help brand owners create the best strategies to promote and protect their brand.
This white paper provides a brief overview of these three software tools and how they can solve some common brand protection challenges.
The pharmaceutical industry is ever-growing, changing and fast-paced. It must adapt to the needs of patients, meet standards set forth by various world health organizations and comply with many international legislations.
Manufacturers, wholesalers, and CMOs will soon have the obligation to guarantee the authenticity of any rescription drugs by identifying individual packs and checking whether the outer packaging of medicines has been tampered with.
This white paper aims to guide pharmaceutical companies and CMOs in their struggle to solve print quality issues, eliminate unexpected downtimes related to blister packaging, and gain flexibility.
Discover how OPTEL’s customizable and future-proof solutions can help you get ready for any upcoming medical device UDI regulation, according to your level of IT integration, and get specific tips, examples and useful information on successful UDI implementation.
This article was specially written to help pharmaceutical companies plan compliance with upcoming serialization laws.
When it comes to serialization, there are currently two main viewpoints on how to go about implementation.
The U.S. serialization compliance deadline is now just around the corner.